Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.70149 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Manar Elsayed und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: International Classification of Diseases, Immune Checkpoint Inhibitors, Arthritis, Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Carrie Ye was supported by a Canadian Institutes of Health Research Early Career Research Award, the Canadian Institutes of Health Research, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
Immune checkpoint inhibitors (ICIs) for cancer can lead to immune‐related adverse events, including ICI‐associated inflammatory arthritis (ICI‐IA). There are no validated International Classification of Diseases (ICD) code–based case definitions for ICI‐IA.
Methods
We conducted a validation study using the Canadian Research Group of Rheumatology in Immuno‐Oncology (CanRIO) database. Rheumatologist‐confirmed ICI‐IA was the reference standard, defined as new onset of at least one swollen joint on examination or synovitis on imaging following ICI exposure, without another cause or pre‐existing IA. We compared ICD‐9 (714.x and 696.0) and ICD‐10 (M05.x, M06.x, and M07.x) IA diagnostic codes against the reference standard. Seven core case definitions of different combinations of ICD codes from the Physician Claims Database (PCD) and the Discharge Abstract Database were tested. Results were stratified by sex. Sensitivity testing with additional criteria was also evaluated.
Results
We included 228 patients in the final analysis: 100 with ICI‐IA and 128 without ICI‐IA. Sensitivity of the tested case definitions ranged from 1.0% to 88.0%, whereas specificity ranged from 86.7% to 100.0%. The case definition with at least one PCD IA code achieved the best balance of sensitivity (88.0%, 95% confidence interval [CI] 81.6%–94.4%) and specificity (86.7%, 95% CI 80.8%–92.6%). Case definition performances were similar between sexes. Additional criteria minimally improved specificity but sacrificed sensitivity.
Conclusion
ICD code–based case definitions of ICI‐IA can accurately detect ICI‐IA and can be used to support ICI‐IA surveillance and research with administrative health data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Alberta, Edmonton, Alberta, Canada.
- Provincial Research Data Services, Alberta Health Services, Edmonton, Alberta, Canada.
- Data and Research Services, Alberta SPOR SUPPORT Unit, Edmonton, Canada.
- University of Manitoba, Winnipeg, Manitoba, Canada.
- McGill University, Montreal, Quebec, Canada.
- University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Manar Elsayed, Zoe Hsu, Finlay A McAlister, William D Leslie, Lisa M Lix, Sasha Bernatsky, Suzanne N Morin, Michelle M Graham, Aurore Fifi-Mah, Shahin Jamal, Janet Roberts, Carrie Ye
Förderung
- Carrie Ye was supported by a Canadian Institutes of Health Research Early Career Research Award
- the Canadian Institutes of Health Research
- Canadian Institutes of Health Research
Zitieren
APA
Elsayed, M., Hsu, Z., McAlister, F. A., Leslie, W. D., Lix, L. M., Bernatsky, S., Morin, S. N., Graham, M. M., Fifi-Mah, A., Jamal, S., Roberts, J., & Ye, C. (2026). Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data. Arthritis & Rheumatology. https://doi.org/10.1002/art.70149
Vancouver
Elsayed M, Hsu Z, McAlister FA, Leslie WD, Lix LM, Bernatsky S, et al. Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data. Arthritis & Rheumatology. 2026. doi:10.1002/art.70149
BibTeX
@article{Elsayed2026,
author = {Elsayed, Manar and Hsu, Zoe and McAlister, Finlay A and Leslie, William D and Lix, Lisa M and Bernatsky, Sasha and Morin, Suzanne N and Graham, Michelle M and Fifi-Mah, Aurore and Jamal, Shahin and Roberts, Janet and Ye, Carrie},
title = {Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.70149}
}
EUVIMED